Hip fracture is a major public health concern due to its poor outcome and serious socioeconomic burden in older people ([@CIT0001]). Evidence has shown that many factors are related to increased risk of hip fracture, but psychiatric diseases are not confirmatory ([@CIT0002], [@CIT0003]). A case-control study by Howard et al. in the United Kingdom has shown that schizophrenia is associated with increased risk of hip fracture in univariate analysis (odds ratio \[OR\]=1.73, 95% CI=1.32--2.28), but association is no longer found in multivariate analysis ([@CIT0003]). To date, no clinical study has focused on the relationship between schizophrenia and the risk of hip fracture in older people in Taiwan. In order to clarify this issue, we used the database from the Taiwan National Health Insurance program to conduct this population-based cohort study. The details of the insurance program can be found in previous studies ([@CIT0004]--[@CIT0006]).

In this study, we randomly selected 445 subjects aged 65 years or older with newly diagnosed schizophrenia as the case group based on the diagnosis codes of the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9 codes 295 and V11.0, 210 men and 235 women, mean age \[standard deviation\]=75.2 \[6.9\] years) and 1,780 subjects aged 65 years or older without schizophrenia as the comparison group (840 men and 940 women, mean age \[standard deviation\]=74.2 \[7.1\] years), from 2000 to 2010. Both groups were matched for gender, age and year of diagnosis. We measured the incidence of hip fracture (ICD-9 codes 820) until either hip fracture was diagnosed or until 31 December 2010. To reduce the biased results, subjects with hip fracture diagnosed before entering this cohort were excluded.

The schizophrenia group had a significantly higher incidence of hip fracture than did the non-schizophrenia group (20.3 vs. 10.6 per 1,000 person-years, incidence rate ratio \[IRR\]=1.91, 95% CI=1.49--2.44). The subanalysis stratified by gender and age group also displayed that the incidence rates of hip fracture were all higher in the schizophrenia group than that in the non-schizophrenia group, with statistical significance. Men with schizophrenia had a higher risk of hip fracture than did women with schizophrenia (IRR 3.26 vs. 1.42). Subjects with schizophrenia aged 75--84 had the highest incidence than other subgroups (incidence rate=35.4 per 1,000 person-years), but subjects with schizophrenia aged 65--74 had a higher risk of hip fracture (IRR=2.14, 95% CI=1.51--3.02). The risk of hip fracture was higher among subjects with a duration of diagnosing schizophrenia of less than 2 years (IRR=2.82, 95% CI=2.16--3.69), as compared to those with a duration ≥2 years (IRR=1.54, 95% CI=1.14--2.07) ([Table 1](#T0001){ref-type="table"}).

###### 

Incidence rates of hip fracture for schizophrenia group and non-schizophrenia group

                     Non-schizophrenia   Schizophrenia                                             
  ------------------ ------------------- --------------- -------- ------ ----- ---- ------- ------ -------------------
  All                1,780               113             10,640   10.6   445   42   2,072   20.3   1.91 (1.49, 2.44)
  Gender                                                                                           
   Men               840                 30              4,770    6.29   210   17   830     20.5   3.26 (2.27, 4.67)
   Women             940                 83              5,870    14.1   235   25   1,242   20.1   1.42 (1.02, 1.99)
  Age group (year)                                                                                 
   65--74            956                 37              6,611    5.60   239   16   1,338   12.0   2.14 (1.51, 3.02)
   75--84            824                 76              4,029    18.9   206   26   734     35.4   1.88 (1.34, 2.64)
  Follow-up period                                                                                 
   \<2 years         340                 29              3,232    8.97   130   19   751     25.3   2.82 (2.16, 3.69)
   ≥2 years          1,440               84              7,408    11.3   315   23   1,321   17.4   1.54 (1.14, 2.07)

Incidence rate: per 1,000 person-years.

Incidence rate ratio: schizophrenia vs. non-schizophrenia (95% CI).

A case-control study by Bolton et al. in Canada has shown that schizophrenia is associated with increased risk of osteoporotic fractures after being adjusted for covariates (OR=1.61, 95% CI=1.27--2.04) but not focusing on hip fracture ([@CIT0007]). In this study, patients with schizophrenia have a 1.9-fold increased risk of hip fracture. In further analysis, we also found that the risk of hip fracture is 2.8-fold in patients with duration of less than 2 years after diagnosing schizophrenia, as compared to subjects without schizophrenia. This means that more efforts should be made to prevent falls in older people with schizophrenia, particularly in the first 2 years of diagnosis. Due to inconsistent results from the aforementioned studies, additional studies are needed to determine the relationship between schizophrenia and hip fracture incidence in older people.
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